GENPHARM LTD
ActiveKey figures
Ratios
2024/25Sector comparison
SIC 70229Where the company stands among the 206,475 active companies whose first SIC code is 70229 (Management consultancy activities other than financial management).
- RECKITT BENCKISER CORPORATE SERVICES LIMITED£3.9bn
- ACCENTURE (UK) LIMITED£2.8bn
- NEW DATA VISION LTD£1.5bn
- CHAILEASE INTERNATIONAL COMPANY (UK) LIMITED£1.1bn
- URBAN LOGISTICS HOLDINGS LIMITED£697.2m
- PA CONSULTING GOVERNMENT SERVICES LIMITED£607.3m
- ATKINSRÉALIS UK LIMITED£408m
- AON SOLUTIONS UK LIMITED£316.3m
- DUNNHUMBY LIMITED£244.3m
- TENEO BUSINESS CONSULTING LIMITED£228.7m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 206,475. The line on each bar marks the median.
Summary: GENPHARM LTD
What kind of company is it?
GENPHARM LTD is a private limited company registered with Companies House under company number 14906078. It was incorporated on 31 May 2023. Its status is active. The registered office is in London (EC1V). Its nature of business (SIC 2007) is management consultancy activities other than financial management (70229), other business support service activities n.e.c. (82990), general medical practice activities (86210).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Turnover was £4,679. Loss for the year was £11. Net assets were £1,302, up 130,100% on the previous year. Cash at bank and in hand was £1,302. The company had an average of 1 employee. Figures are available for 2 financial years (2023/24–2024/25).
How does it compare with similar companies?
Compared with 206,475 active companies whose first SIC code is 70229: By turnover it ranks lower than 76% of the 2,414 that publish turnover (median £40,863). By net assets it ranks lower than 68% of them (median £8,998). By total assets it ranks lower than 89% of them (median £32,370). By cash it ranks lower than 82% of them (median £17,475). By number of employees it is around the median of them (1). It is younger than 60% of them (median age 5.0 years).
Who runs and controls the company?
The company has 1 current director. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 13 Jun 2027.
Filed accounts2023/24–2024/25
| 2023/24 | 2024/25 | |
|---|---|---|
| Turnover | — | 4,679 |
| Profit for the year | — | -11 |
| Cash at bank and in hand | 1 | 1,302 |
| Total assets | — | 1,302 |
| Total liabilities | — | — |
| Net assets / total equity | 1 | 1,302 |
| Average number of employees | — | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
History
7 events- Financial year 2024/25 endedAccounts: turnover £4,679, net assets £1,302, 1 employee
- Name changed to GENPHARM LTDPreviously THE COLLECTIVE ENTERPRISE GLOBAL LTD
- Financial year 2023/24 endedAccounts: net assets £1
- Genevieve BOATENG appointedSecretary
- Genevieve Boatemaa BOATENG appointedDirector
- Miss Genevieve Boatemaa Boateng registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.